APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2

APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献

基本信息

项目摘要

The inheritance of APOEε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease (LOAD). In fact, the inheritance of APOEε4 allele is the strongest known genetic risk factor in human pathology, but the mechanism is poorly understood. In contrast, APOEε2 allele is protective for AD and age-related diseases AD. While APOE has been associated with critical cellular functions such as oxidative processes, inflammation, glial cell and neuronal homeostasis, none of those can be dissociated from binding, transport and delivery of choles- terol and phospholipids to different cell types by APOE containing lipoprotein particles. It is also uniformly ac- cepted that the above functions are APOE-isoform specific. Our preliminary data demonstrates that phospholipid composition of APOEε3/3 and APOEε4/4 AD brain differs significantly. Most prominent were changes in lipid classes that are critical in regulation of normal mitochondrial function and dynamics, but also in execution of metabolic cascades part of regulated intracellular protein degradation known as autophagy and mitophagy. We also found significant APOE isoform-specific differences between the transcriptomic profiles of the AD samples that substantiate molecular explanation of specific AD pathological changes in brain, based on perturbed gene expression. Our preliminary data also demonstrates that there is a significant difference in the phospholipid content of native APOE2, APOE3- and APOE4- lipoproteins suggesting that that they may affect differentially surface immune receptors and initiate different signal transduction cascades. We hypothesize that the APOE isoform-specific effects on phenotype are driven by the different phospholipid composition of APOE lipid particles and/or by the differential effect of APOE isoforms on brain transcriptome and lipidome. In the First SA, we will establish the association of APOE alleles with AD brain transcriptome and lipidome and determine the allele specific impact on mitochondrial function and dynamics. We will use postmor- tem brain samples from AD patients and controls of different APOE genotypes to determine differences in tran- scriptomes and lipidomes within and between genotypes. We will generate and analyze correlated/co-expressed gene networks based on APOE allele associated differentially expressed genes and perform correlation analyses to identify associations between genes and lipids in brain. In the Second SA, we will investigate APOE isoform- dependent epigenetic and transcriptomic changes in AD brain and APOE Targeted Replacement mice. We will determine the enrichment of histone marks in specific cell types isolated from human AD and control brains and will examine APOE allele specific correlations to gene expression profiles. Next, we will examine the effect of aging on epigenome and transcriptome in distinct brain cell types of human APOE TR mice. In the Third SA, we will determine how APOE2 lipoproteins counteract the acute deleterious effects of A. The goals are to examine the effect of APOE2, E3 and E4 lipoproteins on: transcriptome of distinct brain cell populations and cognition in mice following intracranial injection of A
APOEε4 等位基因的遗传是晚发性阿尔茨海默病 (LOAD) 最强的遗传风险因素。 事实上,APOEε4 等位基因的遗传是人类病理学中已知最强的遗传风险因素,但 机制尚不清楚。相比之下,APOEε2 等位基因对 AD 和年龄相关疾病 AD 具有保护作用。 虽然 APOE 与氧化过程、炎症、神经胶质细胞等关键细胞功能相关。 细胞和神经元的稳态,这些都不能与胆汁的结合、运输和递送分离。 通过含有脂蛋白颗粒的 APOE 将特醇和磷脂作用于不同的细胞类型。它也是统一ac- 认为上述功能是 APOE 同种型特有的。我们的初步数据表明,磷脂 APOEε3/3 和 APOEε4/4 AD 大脑的组成存在显着差异。最显着的是血脂的变化 对正常线粒体功能和动力学的调节至关重要的类别,而且对执行 代谢级联是调节细胞内蛋白质降解的一部分,称为自噬和线粒体自噬。我们 还发现 AD 样本的转录组谱之间存在显着的 APOE 同工型特异性差异 基于扰动基因证实了大脑中特定 AD 病理变化的分子解释 表达。我们的初步数据还表明,磷脂存在显着差异。 天然 APOE2、APOE3- 和 APOE4- 脂蛋白的含量表明它们可能会产生不同的影响 表面免疫受体并启动不同的信号转导级联。 我们假设 APOE 异构体对表型的特异性影响是由不同的磷脂驱动的 APOE 脂质颗粒的组成和/或 APOE 亚型对脑转录组的不同影响和 脂质组。在第一个 SA 中,我们将建立 APOE 等位基因与 AD 脑转录组的关联,并 脂质组并确定等位基因对线粒体功能和动力学的具体影响。我们将使用事后 对 AD 患者和不同 APOE 基因型对照的大脑样本进行 TEM 分析,以确定转录组的差异 基因型内和基因型之间的脚本组和脂质组。我们将生成并分析相关/共同表达 基于APOE等位基因关联差异表达基因的基因网络并进行相关性分析 确定大脑中基因和脂质之间的关联。在第二个 SA 中,我们将研究 APOE 亚型 - AD 大脑和 APOE 靶向替代小鼠中依赖的表观遗传和转录组变化。我们将 确定从人类 AD 和对照大脑中分离的特定细胞类型中组蛋白标记的富集情况 并将检查 APOE 等位基因与基因表达谱的特异性相关性。接下来,我们将检查 衰老对人类 APOE TR 小鼠不同脑细胞类型的表观基因组和转录组的影响。在 第三个 SA,我们将确定 APOE2 脂蛋白如何抵消 A 的急性有害作用。目标 将检查 APOE2、E3 和 E4 脂蛋白对以下方面的影响: 不同脑细胞群的转录组 颅内注射 A 后小鼠的认知和认知能力

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RADOSVETA KOLDAMOVA其他文献

RADOSVETA KOLDAMOVA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RADOSVETA KOLDAMOVA', 18)}}的其他基金

The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
  • 批准号:
    10447273
  • 财政年份:
    2022
  • 资助金额:
    $ 63.59万
  • 项目类别:
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
  • 批准号:
    10634661
  • 财政年份:
    2022
  • 资助金额:
    $ 63.59万
  • 项目类别:
ncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkers
AD 患者血浆 EV 中的 ncRNA 及其作为生物标志物的区分能力
  • 批准号:
    10532000
  • 财政年份:
    2022
  • 资助金额:
    $ 63.59万
  • 项目类别:
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2
APOE 在衰老大脑和 AD 中精心设计的分子特征——APOE2 的贡献
  • 批准号:
    10170188
  • 财政年份:
    2018
  • 资助金额:
    $ 63.59万
  • 项目类别:
APOE orchestrated ''molecular signatures'' in aging brain and AD - the contribution of APOE2
APOE 在衰老大脑和 AD 中精心策划了“分子特征”——APOE2 的贡献
  • 批准号:
    9555298
  • 财政年份:
    2017
  • 资助金额:
    $ 63.59万
  • 项目类别:
Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD
砷的表观遗传和表型效应:对认知和 AD 的影响
  • 批准号:
    8755745
  • 财政年份:
    2014
  • 资助金额:
    $ 63.59万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8103681
  • 财政年份:
    2011
  • 资助金额:
    $ 63.59万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8484324
  • 财政年份:
    2011
  • 资助金额:
    $ 63.59万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8277207
  • 财政年份:
    2011
  • 资助金额:
    $ 63.59万
  • 项目类别:
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo models
LXR 和人 ApoE 亚型对 AD 表型的影响:体外和体内模型
  • 批准号:
    8665344
  • 财政年份:
    2011
  • 资助金额:
    $ 63.59万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 63.59万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了